Business ❯ Pharmaceutical Industry ❯ Drug Manufacturers ❯ Pricing Strategies

Market Competition

Trump Adds Nine Pharma Giants to Drug Pricing Deals, Reaching 14 Signatories as TrumpRx Nears Launch

The voluntary MFN agreements promise lower Medicaid prices with cash-purchase discounts via TrumpRx.gov starting in January.

Medicare’s First Negotiated Drug Prices Take Effect Jan. 1, Cutting 2026 Costs

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

White House Seals Deals With Lilly and Novo to Cut GLP-1 Costs, Pilot Medicare Coverage

White House Clinches Pfizer Pricing Deal Tied to Tariff Reprieve and $70 Billion U.S. Investment

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

Trump Gives Pharma Until September 29 to Match Lowest Global Drug Prices

Trump Gives Pharma CEOs 60 Days to Adopt Most-Favored-Nation Drug Pricing